Radiation Effects on Methamphetamine Pharmacokinetics and Pharmacodynamics in Rats

Area of Science:

• Pharmacology
• Toxicology
• Radiation Biology

Background:

• Whole-body radiation exposure impacts drug pharmacokinetics, but effects on psychoactive medications are poorly understood.
• Altered pharmacokinetics of psychoactive drugs post-radiation may lead to reduced efficacy or increased toxicity.

Purpose of the Study:

• To investigate the effects of acute radiation exposure on the pharmacokinetics and pharmacodynamics of methamphetamine.
• To assess how different radiation doses (1, 3, and 6 Gy) influence drug behavior in the body.

Main Methods:

• Male Wistar rats were exposed to 0, 1, 3, or 6 Gy X-ray radiation.
• Serum pharmacokinetics, methamphetamine-induced locomotor activity, and brain concentrations were measured.
• Renal and hepatic biomarkers and liver histology were assessed post-exposure.

Main Results:

• A 6 Gy radiation dose significantly reduced peak methamphetamine concentrations and its metabolite exposure (AUC).
• Locomotor activity and the brain-to-serum concentration ratio of methamphetamine were significantly elevated after 6 Gy exposure.
• Serum half-life and urine clearance of methamphetamine remained unaffected by radiation doses.

Conclusions:

• Radiation doses up to 6 Gy did not alter methamphetamine elimination.
• A 6 Gy dose impacted methamphetamine's subcutaneous absorption and brain distribution.
• Consideration of these radiation-induced drug distribution changes is essential for clinical practice.